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Abstract
Background: Schmallenberg virus (SBV) is an emerging Orthobunyavirus of ruminant livestock species currently
circulating in Europe. SBV causes a subclinical or mild disease in adult animals but vertical transmission to pregnant
dams may lead to severe malformations in the offspring. Data on the onset of clinical signs, viremia and
seroconversion in experimentally infected adult animals are available for cattle and sheep but are still lacking for
goats.
For a better understanding of the pathogenesis of SBV infection in adult ruminants, we carried out experimental
infections in adult goats. Our specific objectives were: (i) to record clinical signs, viremia and seroconversion; (ii) to
monitor viral excretion in the semen of infected bucks; (iii) to determine in which tissues SBV replication took place
and virus-induced lesions developed.
Results: Four goats and two bucks were inoculated with SBV. Virus inoculation was followed by a short viremic
phase lasting 3 to 4 days and a seroconversion occurring between days 7 and 14 pi in all animals. The inoculated
goats did not display any clinical signs, gross lesions or histological lesions. Viral genomic RNA was found in one
ovary but could not be detected in other organs. SBV RNA was not found in the semen samples collected from
two inoculated bucks.
Conclusions: In the four goats and two bucks, the kinetics of viremia and seroconversion appeared similar to those
previously described for sheep and cattle. Our limited set of data provides no evidence of viral excretion in buck
semen.
Background
In the late summer/autumn 2011, a disease outbreak with
diarrhea, drop of milk production, and fever was reported
in adult cattle in Western Europe. These symptoms
could not be attributed to any known infectious
agent. Metagenomic analyses on blood samples from
affected animals in Germany led to the identification
of a new Orthobunyavirus that was named the
Schmallenberg virus (SBV) [1]. This emerging virus
was later found to induce teratogenesis in pregnant
cattle, sheep, and goats leading to typical malforma-
tions in the offspring [2].
Experimental infections of adult sheep and cattle with
SBV resulted in subclinical infections with a short viremic
phase. Seroconversion in the infected animals occurred
about two weeks post inoculation (pi) [1, 3–5]. To our
knowledge, no report on the pathogenesis of experimental
SBV infections in adult goats has been published.
SBV is transmitted by biting midges (Culicoides spp.).
The possibility of sexual transmission between rumi-
nants has not yet been elucidated [2]. Infectious SBV has
been detected in bovine semen samples from the field
[6–8] and SBV RNA could be detected in semen from
experimentally infected bulls [9]. Whether SBV can be
excreted in buck semen is still unknown.
In this study, we carried out experimental infections of
SBV in adult goats. Our specific objectives were: (i) to
record the development of clinical signs, viremia and
seroconversion in goats; (ii) to monitor the excretion of
SBV in buck semen after inoculation; (iii) to determine
in which tissues SBV replication took place and virus-
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induced lesions developed in adult bucks and non-gravid
goats, with special emphasis on the genital tract.
Methods
All experiments were conducted in accordance with the
guidelines of the Council European Directive (2010/63/
UE). All experimental procedures were approved by the
ethical review board of the Val de Loire (CEEA VdL,
committee number n°19, number 2012-02-11).
Experimental design
Five adult Alpine goats, one adult Saanen buck and one
adult Alpine buck were purchased from local breeders
(INRA Center, Bourges, France) and were housed in the
Biosafety Level 3 and insect-proof animal facilities of the
National Institute of Agricultural Research (INRA),
Research Loire Valley Center (PFIE, Nouzilly, France).
All purchased animals were SBV-negative as determined
by ELISA and RT-qPCR.
Two goats (designated A and B) were inoculated sub-
cutaneously on day 0 with 1 mL of SBV-containing bovine
serum kindly provided by the Friedrich-Loeffler-Institut
(FLI), Germany [3]. Two goats (designated C and D) were
inoculated on day 0 with 1 mL of SBV-containing ovine
whole blood collected at the PFIE during a previous ex-
perimental infection trial [5]. One goat from each group
was killed at day 7 pi and the remaining goats were killed
at day 14 pi. The two bucks (designated E and F) were in-
oculated subcutaneously at day 0 with 1 mL of the FLI
serum and killed at day 28 pi. One goat (designated G)
was inoculated subcutaneously on day 0 with 1 mL of ster-
ile saline solution and served as an in-contact negative
control until it was killed at day 28 pi.
During the course of the trial, all animals were moni-
tored twice daily, and body temperatures were recorded
by telemetric measurement with rumen temperature
sensors (Small Bolus®, Médria, Châteaubourg–France).
After inoculation, whole blood and serum samples were
collected daily during the first week and then at days 14
and 28 pi. Buck semen was collected at day 0 and then
twice a week. At necropsy, all the organs were macro-
scopically evaluated and a panel of tissue samples was
collected for histopathology and RT-qPCR (spleen, pre-
scapular lymph node, skeletal muscle, aorta, liver, kidney,
lung, small intestine, brain, skin, ovary, oviduct, uterus,
testis, and epididymis).
Real-time PCR
Ovaries were dissected and follicular fluid, cumulus cells,
oocytes and interstitial tissue were separated from each
other prior to total RNA extraction. RNA from blood
and tissue samples was extracted using the LSI MagVet™
Universal Isolation kit (Life Technologies SAS, Saint-
Aubin, France) and King Fisher magnetic particle
processor (Thermo Scientific™, Illkirch, France) accord-
ing to the manufacturers’ instructions. RNA from semen
samples was extracted with Trizol ® LS Reagent [6].
The samples were then tested for the presence of SBV
RNA by RT-qPCR as previously described [10]. Quantifi-
cation cycle (Cq) threshold value was 40, with higher
values regarded as negative.
Serology
Serum samples were submitted to SBV specific ELISA test-
ing (ID Screen Schmallenberg virus Indirect®, monocupule,
IDvet) and virus neutralization test (VNT) [11].
Histopathological examination
After fixation in 10 % buffered formalin, tissues were
routinely processed, sliced at 4 μm, stained with
Hematoxylin-Eosin-Saffron (HES) and examined by
light microscopy.
Results
Clinical and post-mortem observations
The goats and bucks did not exhibit any clinical signs.
No fever peak was detected in any of the animals. No
significant gross lesion was found at necropsy.
Real-time PCR
SBV RNA was detected in the blood of all inoculated
animals for 3 to 4 days, starting between day 1 and 3 pi
(Fig. 1). From day 6 pi, SBV RNA became undetectable.
Cq values during RNAemia in all animals ranged from
25 to 39. The intensity of RNAemia differed in 2 of the
4 inoculated goats, with goats A and D showing a max-
imal Cq value of about 25 while goats B and C showed a
maximal Cq value of about 35, independently of the
inoculum (ovine EDTA blood or bovine serum). All
sampled tissues scored negative for SBV by RT-qPCR in
Fig. 1 Detection of SBV RNA in blood by RT-qPCR after SBV inoculation
in goats and bucks. A, B: goats inoculated with SBV-containing bovine
serum; C, D: goats inoculated with SBV-containing ovine blood; E, F:
bucks inoculated with SBV-containing bovine serum
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bucks and goats, except for one ovary in goat C (intersti-
tial ovarian tissue with a non-normalized Cq value of
34). The semen from the bucks remained negative for
SBV from day 0 until the end of the trial, as determined
by RT-qPCR.
Serology
The ELISA results for inoculated animals are shown in
Fig. 2. Goats B and C, killed at day 7 pi, remained sero-
negative. Antibodies to SBV were detected in goats A
and D at 14 pi by ELISA and at day 9 pi by VNT (titers:
128 and 96 respectively). Antibodies to SBV were de-
tected in buck E at day 28 pi by ELISA and at day 14 pi
by VNT (titer: 64). Buck F was found seropositive at day
14 pi by ELISA and VNT (titer: 96). The mock-
inoculated goat remained seronegative until day 28 pi
(as determined by ELISA).
Histopathological examination
No significant lesions was found in any of the animals.
Rare coccidian parasites were seen in the intestine from
goats B, C and G.
Discussion
Our results show that, in goats and bucks, inoculation of
SBV is followed by a short viremic phase lasting 3 to
4 days followed by seroconversion between day 7 and
day 14 pi. Importantly, these clear signs of successful
experimental infection were not accompanied by any
clinical sign, including fever.
These observations are in accordance with data from ex-
perimental infection studies with sheep and cattle inocu-
lated subcutaneously with infectious serum. In sheep,
RNAemia was detected a few days after infection and lasted
for 3 to 7 days, while SBV-specific antibodies appeared be-
tween 7 and 9 days pi (detection by VNT) [12] or between
10 and 14 days pi (detection by ELISA) [5]. Data from this
experiment in goats show a trend towards a higher sensitiv-
ity of VNT compared to ELISA at the beginning of the
seroconversion. Poskin et al. [12] had similar observations
in sheep and suggested that this difference could be due to
the ability of VNT to detect both IgM and IgG, while the
ELISA can only detect IgG. Following experimental infec-
tion, sheep did not show any clinical sign [12] or almost no
sign, with diarrhea being reported in one case [5]. In cattle,
RNAemia could be detected for less than a week after in-
oculation [1, 3, 4] with detection by ELISA of SBV-specific
antibodies two weeks pi [3, 4]. Clinical signs were absent
[3, 4] or limited to fever or diarrhea [1].
In cattle and sheep, after experimental inoculation,
SBV genomic RNA was most consistently found in
lymphoid organs, i.e. spleen and lymph nodes, especially
the mesenteric lymph nodes [3–5, 9, 12]. This was not
the case in any of the four goats and two bucks inocu-
lated in the present study; however we did not collect
the mesenteric lymph nodes. The only organ where SBV
genome was found was one ovary of a single goat. Inter-
estingly, the SBV genome had already been found in the
ovary of one experimentally infected sheep [5], but the
significance of this finding remains unknown. No signifi-
cant gross lesions or histological lesions were found in
our study. Similarly, experimental infections of cattle or
sheep did not result in gross lesions at necropsy [3–5, 12].
So far, in experimentally infected adult ruminants, the
presence of SBV genome in a given organ has not been re-
ported to be associated with any lesion in this organ.
No SBV genome was found between day 0 and day 28
pi (end of the trial) in the semen samples obtained from
the two inoculated bucks. This result differs from the
observations made after experimental infection of two
bulls with SBV-containing cell culture supernatants [9].
Viral genome could be detected in the semen of both
bulls for the first week following inoculation and, in the
case of one bull, as late as at day 19 pi (the trial ended at
day 25 pi). SBV excretion in bovine semen has also been
reported from the field [6–8] but, to our knowledge, this
has never been reported for bucks. However, the small
size of our inoculated group precludes a conclusion re-
garding the excretion of SBV in caprine semen and the
risk of sexual transmission.
The data from this study match those from reports of
natural infection by SBV in domestic ruminants: clinical
signs of infection are either mild or absent in adults.
The most important effects of SBV infection are malfor-
mations in the offspring due to vertical transmission in
pregnant dams [2]. A study of the impact of SBV in
French domestic ruminants showed that only 2 % of the
kids born in goat herds with congenital SBV cases showed
Fig. 2 Detection of SBV specific antibodies by ELISA after SBV
inoculation in goats and bucks. A, B: goats inoculated with
SBV-containing bovine serum; C, D: goats inoculated with SBV-
containing ovine blood; E, F: bucks inoculated with SBV-
containing bovine serum. S/P < 60 %: negative; S/P > 70 %:
positive and S/P between 60 % and 70 %: doubtful
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malformations [13]. The same study reported a potential
effect of SBV infection in the early stages of pregnancy,
based on reports of repeated estrus or early embryonic
loss, especially in small ruminants [13]. The effects of SBV
infection in pregnant goats, however, remain to be
elucidated.
Conclusions
Following experimental infection in goats with SBV, the
kinetics of viremia and seroconversion were found to be
similar to earlier reported kinetics in sheep and cattle.
No clinical signs were associated to infection, in agree-
ment with reports from the field. SBV RNA was found
in one ovary but not in other organs. The SBV genome
was not found in semen from the two inoculated bucks
but this limited set of data does not exclude the risk of
viral transmission by artificial insemination or natural
service.
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